Prostate cancer epidemiology in the United States

[1]  K. Hemminki.  Familial risk and familial survival in prostate cancer , 2012, World Journal of Urology.

[2]  J. Marshall.  Diet and prostate cancer prevention , 2012, World Journal of Urology.

[3]  R. Sinha,et al.  Patterns of meat intake and risk of prostate cancer among African-Americans in a large prospective study , 2011, Cancer Causes & Control.

[4]  E. Giovannucci.  Commentary: Serum lycopene and prostate cancer progression: a re-consideration of findings from the prostate cancer prevention trial , 2011, Cancer Causes & Control.

[5]  A. Jemal,et al.  Association of Insurance and Race/Ethnicity with Disease Severity among Men Diagnosed with Prostate Cancer, National Cancer Database 2004-2006 , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[6]  K. Hemminki,et al.  Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members. , 2010, European urology.

[7]  Ziding Feng,et al.  Prostate cancer specific mortality and Gleason 7 disease differences in prostate cancer outcomes between cases with Gleason 4 + 3 and Gleason 3 + 4 tumors in a population based cohort. , 2009, The Journal of urology.

[8]  Peter C Albertsen,et al.  Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. , 2009, Journal of the National Cancer Institute.

[9]  E. Giovannucci,et al.  Dairy intake and 1,25-dihydroxyvitamin D levels in men at high risk for prostate cancer , 2009, Cancer Causes & Control.

[10]  J. Stanford,et al.  Screening, Treatment, and Prostate Cancer Mortality in the Seattle Area and Connecticut: Fifteen-year Follow-up , 2008, Journal of General Internal Medicine.

[11]  K. Cooney,et al.  The androgen receptor CAG and GGN repeat polymorphisms and prostate cancer susceptibility in African-American men: results from the Flint Men's Health Study , 2008, Journal of Human Genetics.

[12]  B. Trock,et al.  Impact of patient age on biochemical recurrence rates following radical prostatectomy. , 2007, The Journal of urology.

[13]  O. Brawley,et al.  Race and disparities in health. , 2007, Current problems in cancer.

[14]  S. Lipsitz,et al.  Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males , 2007, Public Health Nutrition.

[15]  E. Giovannucci.  Tomato products, lycopene, and prostate cancer: a review of the epidemiological literature. , 2005, The Journal of nutrition.

[16]  P. Walsh.  Racial Differences in Initial Treatment for Clinically Localized Prostate Cancer. Results From the Prostate Cancer Outcomes Study , 2004 .

[17]  V. Shavers,et al.  Race/Ethnicity and the Intensity of Medical Monitoring Under ‘Watchful Waiting’ for Prostate Cancer , 2004, Medical care.

[18]  V. Shavers,et al.  Race/ethnicity and the receipt of watchful waiting for the initial management of prostate cancer , 2004, Journal of General Internal Medicine.

[19]  F. Schrōder,et al.  Screening for prostate cancer: have you had your cholesterol measured? , 2004, BJU international.

[20]  Harry J de Koning,et al.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer. , 2003, Journal of the National Cancer Institute.

[21]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[22]  Peter H Gann,et al.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. , 2002, Journal of the National Cancer Institute.

[23]  J. Moul,et al.  Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy. , 2001, Urology.

[24]  E. Feuer,et al.  Role of transurethral resection of the prostate in population-based prostate cancer incidence rates. , 1999, American journal of epidemiology.

[25]  B. Kramer,et al.  Trends and black/white differences in treatment for nonmetastatic prostate cancer. , 1998, Medical care.

[26]  C. Bennett,et al.  Relation between literacy, race, and stage of presentation among low-income patients with prostate cancer. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  E. Crawford,et al.  Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program. The Prostate Cancer Education Council. , 1996, Urology.

[28]  M. Barry,et al.  Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. , 1996, Journal of the National Cancer Institute.

[29]  I. Thompson,et al.  Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. , 1995, JAMA.

[30]  A. Whittemore,et al.  Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. , 1995, Journal of the National Cancer Institute.

[31]  B A Miller,et al.  The role of increasing detection in the rising incidence of prostate cancer. , 1995, JAMA.

[32]  W. Catalona,et al.  Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.

[33]  L. Tanoue.  Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths , 2012 .

[34]  V. Master,et al.  Grade migration in prostate cancer: an analysis using the Surveillance, Epidemiology, and End Results registry , 2007, Prostate Cancer and Prostatic Diseases.

[35]  R. Hayes,et al.  Dietary factors and risks for prostate cancer among blacks and whites in the United States. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.